Advertisement
Screener

AGENUS INC (AGEN) Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Forfeited in Period

AGENUS INC Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Forfeited in Period

AGENUS INC (AGEN) reported Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Forfeited in Period of 85.64 thousand shares for the 12-month period ending 2025-12-31, per its 10-K filed 2026-03-16.

Financial Statements › Notes › Compensation Related Costs › Share-Based Payment Arrangement, Disclosure

us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod · last filed 2026-03-16

  • AGENUS INC share-based compensation arrangement by share-based payment award, equity instruments other than options, forfeited in period for the quarter ending 2025-12-31 was 75.00K shares, a 7400.00% increase year-over-year.
  • AGENUS INC share-based compensation arrangement by share-based payment award, equity instruments other than options, forfeited in period for the quarter ending 2025-09-30 was 37.00 shares, a 99.68% decline year-over-year.
  • AGENUS INC share-based compensation arrangement by share-based payment award, equity instruments other than options, forfeited in period for the quarter ending 2025-06-30 was 4.26K shares.
  • AGENUS INC share-based compensation arrangement by share-based payment award, equity instruments other than options, forfeited in period for the quarter ending 2025-03-31 was 6.33K shares, a 58.33% increase year-over-year.
  • AGENUS INC share-based compensation arrangement by share-based payment award, equity instruments other than options, forfeited in period for fiscal 2025 was 85.64K shares, a 419.00% increase from fiscal 2024.
  • AGENUS INC share-based compensation arrangement by share-based payment award, equity instruments other than options, forfeited in period for fiscal 2024 was 16.50K shares, a 96.37% decline from fiscal 2023.
  • AGENUS INC share-based compensation arrangement by share-based payment award, equity instruments other than options, forfeited in period for fiscal 2023 was 454.22K shares, a 42.10% decline from fiscal 2022.
  • AGENUS INC share-based compensation arrangement by share-based payment award, equity instruments other than options, forfeited in period for fiscal 2022 was 784.50K shares, a 1048.04% increase from fiscal 2021.
Period endShare-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Forfeited in Period 3 monthShare-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Forfeited in Period 6 monthShare-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Forfeited in Period 9 monthShare-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Forfeited in Period 12 month
2025-12-3175.00K shares
derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-16
75.04K shares
derived: sum of 2 quarters · filed 2026-03-16
79.30K shares
derived: sum of 3 quarters · filed 2026-03-16
85.64K shares
10-K · filed 2026-03-16
2025-09-3037.00 shares
derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-10
4.30K shares
derived: sum of 2 quarters · filed 2025-11-10
10.63K shares
10-Q · filed 2025-11-10
11.63K shares
derived: sum of 4 quarters · filed 2025-11-10
2025-06-304.26K shares
derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-11
10.60K shares
10-Q · filed 2025-08-11
11.60K shares
derived: sum of 3 quarters · filed 2025-08-11
23.10K shares
derived: sum of 4 quarters · filed 2025-08-11
2025-03-316.33K shares
10-Q · filed 2025-05-12
7.33K shares
derived: sum of 2 quarters · filed 2025-05-12
18.83K shares
derived: sum of 3 quarters · filed 2025-05-12
18.83K shares
derived: sum of 4 quarters · filed 2025-05-12
2024-12-311.00K shares
derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-17
12.50K shares
derived: sum of 2 quarters · filed 2025-03-17
12.50K shares
derived: sum of 3 quarters · filed 2025-03-17
16.50K shares
10-K · filed 2025-03-17
2024-09-3011.50K shares
derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-12
11.50K shares
derived: sum of 2 quarters · filed 2024-11-12
15.50K shares
10-Q · filed 2024-11-12
234.72K shares
derived: sum of 4 quarters · filed 2024-11-12
2024-06-300.00 shares
derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-08
4.00K shares
10-Q · filed 2024-08-08
223.22K shares
derived: sum of 3 quarters · filed 2024-08-08
338.22K shares
derived: sum of 4 quarters · filed 2024-08-08
2024-03-314.00K shares
10-Q · filed 2024-05-07
223.22K shares
derived: sum of 2 quarters · filed 2024-05-07
338.22K shares
derived: sum of 3 quarters · filed 2024-05-07
2023-12-31219.22K shares
derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-14
334.22K shares
derived: sum of 2 quarters · filed 2024-03-14
454.22K shares
10-K · filed 2024-03-14
2023-09-30115.00K shares
derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-09
235.00K shares
10-Q · filed 2023-11-09
2023-06-30120.00K shares
10-Q · filed 2023-08-08
2022-12-3153.33K shares
derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-16
107.50K shares
derived: sum of 2 quarters · filed 2023-03-16
137.50K shares
derived: sum of 3 quarters · filed 2023-03-16
784.50K shares
10-K · filed 2023-03-16
2022-09-3054.17K shares
derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-08
84.17K shares
derived: sum of 2 quarters · filed 2022-11-08
731.17K shares
10-Q · filed 2022-11-08
769.50K shares
derived: sum of 4 quarters · filed 2022-11-08
2022-06-3030.00K shares
derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-09
677.00K shares
10-Q · filed 2022-08-09
715.33K shares
derived: sum of 3 quarters · filed 2022-08-09
2022-03-31647.00K shares
10-Q · filed 2022-05-10
685.33K shares
derived: sum of 2 quarters · filed 2022-05-10
2021-12-3138.33K shares
derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-01
68.33K shares
10-K · filed 2022-03-01
2021-09-3030.00K shares
10-Q · filed 2021-11-09
2020-12-3115.00K shares
derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-16
15.00K shares
derived: sum of 2 quarters · filed 2021-03-16
15.00K shares
derived: sum of 3 quarters · filed 2021-03-16
1.34M shares
10-K · filed 2021-03-16
2020-09-300.00 shares
derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-09
0.00 shares
derived: sum of 2 quarters · filed 2020-11-09
1.32M shares
10-Q · filed 2020-11-09
1.38M shares
derived: sum of 4 quarters · filed 2020-11-09
2020-06-300.00 shares
derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-10
1.32M shares
10-Q · filed 2020-08-10
1.38M shares
derived: sum of 3 quarters · filed 2020-08-10
1.43M shares
derived: sum of 4 quarters · filed 2020-08-10
2020-03-311.32M shares
10-Q · filed 2020-05-11
1.38M shares
derived: sum of 2 quarters · filed 2020-05-11
1.43M shares
derived: sum of 3 quarters · filed 2020-05-11
1.44M shares
derived: sum of 4 quarters · filed 2020-05-11
2019-12-3158.49K shares
derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-16
111.38K shares
derived: sum of 2 quarters · filed 2020-03-16
117.88K shares
derived: sum of 3 quarters · filed 2020-03-16
702.16K shares
10-K · filed 2020-03-16
2019-09-3052.89K shares
derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-07
59.39K shares
derived: sum of 2 quarters · filed 2019-11-07
643.67K shares
10-Q · filed 2019-11-07
680.83K shares
derived: sum of 4 quarters · filed 2019-11-07
2019-06-306.50K shares
derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-09
590.79K shares
10-Q · filed 2019-08-09
627.94K shares
derived: sum of 3 quarters · filed 2019-08-09
639.50K shares
derived: sum of 4 quarters · filed 2019-08-09
2019-03-31584.28K shares
10-Q · filed 2019-05-10
621.44K shares
derived: sum of 2 quarters · filed 2019-05-10
633.00K shares
derived: sum of 3 quarters · filed 2019-05-10
674.25K shares
derived: sum of 4 quarters · filed 2019-05-10
2018-12-3137.15K shares
derived: 10-K 12 month − 10-Q 9 month · filed 2019-03-18
48.72K shares
derived: sum of 2 quarters · filed 2019-03-18
89.97K shares
derived: sum of 3 quarters · filed 2019-03-18
89.97K shares
10-K · filed 2019-03-18
2018-09-3011.56K shares
derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-07
52.81K shares
derived: sum of 2 quarters · filed 2018-11-07
52.81K shares
10-Q · filed 2018-11-07
142.81K shares
derived: sum of 4 quarters · filed 2018-11-07
2018-06-3041.25K shares
derived: 10-Q 6 month − 10-Q 3 month · filed 2018-08-09
41.25K shares
10-Q · filed 2018-08-09
131.25K shares
derived: sum of 3 quarters · filed 2018-08-09
244.46K shares
derived: sum of 4 quarters · filed 2018-08-09
2018-03-310.00 shares
10-Q · filed 2018-05-10
90.00K shares
derived: sum of 2 quarters · filed 2018-05-10
203.21K shares
derived: sum of 3 quarters · filed 2018-05-10
212.38K shares
derived: sum of 4 quarters · filed 2018-05-10
2017-12-3190.00K shares
derived: 10-K 12 month − 10-Q 9 month · filed 2018-03-16
203.21K shares
derived: sum of 2 quarters · filed 2018-03-16
212.38K shares
derived: sum of 3 quarters · filed 2018-03-16
242.98K shares
10-K · filed 2018-03-16
2017-09-30113.21K shares
derived: 10-Q 9 month − 10-Q 6 month · filed 2017-11-07
122.38K shares
derived: sum of 2 quarters · filed 2017-11-07
152.98K shares
10-Q · filed 2017-11-07
209.03K shares
derived: sum of 4 quarters · filed 2017-11-07
2017-06-309.17K shares
derived: 10-Q 6 month − 10-Q 3 month · filed 2017-08-07
39.77K shares
10-Q · filed 2017-08-07
95.82K shares
derived: sum of 3 quarters · filed 2017-08-07
194.97K shares
derived: sum of 4 quarters · filed 2017-08-07
2017-03-3130.60K shares
10-Q · filed 2017-05-04
86.65K shares
derived: sum of 2 quarters · filed 2017-05-04
185.79K shares
derived: sum of 3 quarters · filed 2017-05-04
234.42K shares
derived: sum of 4 quarters · filed 2017-05-04
2016-12-3156.05K shares
derived: 10-K 12 month − 10-Q 9 month · filed 2017-03-16
155.19K shares
derived: sum of 2 quarters · filed 2017-03-16
203.81K shares
derived: sum of 3 quarters · filed 2017-03-16
215.03K shares
10-K · filed 2017-03-16
2016-09-3099.15K shares
derived: 10-Q 9 month − 10-Q 6 month · filed 2016-11-09
147.77K shares
derived: sum of 2 quarters · filed 2016-11-09
158.98K shares
10-Q · filed 2016-11-09
190.56K shares
derived: sum of 4 quarters · filed 2016-11-09
2016-06-3048.62K shares
derived: 10-Q 6 month − 10-Q 3 month · filed 2016-08-04
59.84K shares
10-Q · filed 2016-08-04
91.41K shares
derived: sum of 3 quarters · filed 2016-08-04
119.35K shares
derived: sum of 4 quarters · filed 2016-08-04
2016-03-3111.21K shares
10-Q · filed 2016-05-09
42.79K shares
derived: sum of 2 quarters · filed 2016-05-09
70.73K shares
derived: sum of 3 quarters · filed 2016-05-09
71.89K shares
derived: sum of 4 quarters · filed 2016-05-09
2015-12-3131.58K shares
derived: 10-K 12 month − 10-Q 9 month · filed 2016-03-15
59.52K shares
derived: sum of 2 quarters · filed 2016-03-15
60.68K shares
derived: sum of 3 quarters · filed 2016-03-15
60.68K shares
10-K · filed 2016-03-15
2015-09-3027.94K shares
derived: 10-Q 9 month − 10-Q 6 month · filed 2015-11-04
29.11K shares
derived: sum of 2 quarters · filed 2015-11-04
29.11K shares
10-Q · filed 2015-11-04
29.11K shares
derived: sum of 4 quarters · filed 2015-11-04
2015-06-301.17K shares
derived: 10-Q 6 month − 10-Q 3 month · filed 2015-08-03
1.17K shares
10-Q · filed 2015-08-03
1.17K shares
derived: sum of 3 quarters · filed 2015-08-03
5.17K shares
derived: sum of 4 quarters · filed 2015-08-03
2015-03-310.00 shares
10-Q · filed 2015-05-01
0.00 shares
derived: sum of 2 quarters · filed 2015-05-01
4.00K shares
derived: sum of 3 quarters · filed 2015-05-01
4.00K shares
derived: sum of 4 quarters · filed 2015-05-01
2014-12-310.00 shares
derived: 10-K 12 month − 10-Q 9 month · filed 2015-03-16
4.00K shares
derived: sum of 2 quarters · filed 2015-03-16
4.00K shares
derived: sum of 3 quarters · filed 2015-03-16
20.21K shares
10-K · filed 2015-03-16
2014-09-304.00K shares
derived: 10-Q 9 month − 10-Q 6 month · filed 2014-10-31
4.00K shares
derived: sum of 2 quarters · filed 2014-10-31
20.21K shares
10-Q · filed 2014-10-31
20.35K shares
derived: sum of 4 quarters · filed 2014-10-31
2014-06-300.00 shares
derived: 10-Q 6 month − 10-Q 3 month · filed 2014-08-01
16.21K shares
10-Q · filed 2014-08-01
16.35K shares
derived: sum of 3 quarters · filed 2014-08-01
16.43K shares
derived: sum of 4 quarters · filed 2014-08-01
2014-03-3116.21K shares
10-Q · filed 2014-05-09
16.35K shares
derived: sum of 2 quarters · filed 2014-05-09
16.43K shares
derived: sum of 3 quarters · filed 2014-05-09
16.43K shares
derived: sum of 4 quarters · filed 2014-05-09
2013-12-31139.00 shares
derived: 10-K 12 month − 10-Q 9 month · filed 2014-03-07
223.00 shares
derived: sum of 2 quarters · filed 2014-03-07
223.00 shares
derived: sum of 3 quarters · filed 2014-03-07
446.00 shares
10-K · filed 2014-03-07
2013-09-3084.00 shares
derived: 10-Q 9 month − 10-Q 6 month · filed 2013-11-08
84.00 shares
derived: sum of 2 quarters · filed 2013-11-08
307.00 shares
10-Q · filed 2013-11-08
307.00 shares
derived: sum of 4 quarters · filed 2013-11-08
2013-06-300.00 shares
derived: 10-Q 6 month − 10-Q 3 month · filed 2013-08-09
223.00 shares
10-Q · filed 2013-08-09
223.00 shares
derived: sum of 3 quarters · filed 2013-08-09
6.74K shares
derived: sum of 4 quarters · filed 2013-08-09
2013-03-31223.00 shares
10-Q · filed 2013-05-10
223.00 shares
derived: sum of 2 quarters · filed 2013-05-10
6.74K shares
derived: sum of 3 quarters · filed 2013-05-10
2012-12-310.00 shares
derived: 10-K 12 month − 10-Q 9 month · filed 2013-03-18
6.51K shares
derived: sum of 2 quarters · filed 2013-03-18
7.17K shares
10-K · filed 2013-03-18
2012-09-306.51K shares
derived: 10-Q 9 month − 10-Q 6 month · filed 2012-11-07
7.17K shares
10-Q · filed 2012-11-07
2012-06-30655.00 shares
10-Q · filed 2012-08-08

Similar stocks

Stock NameCountryMarket CapPE Ratio
C4 Therapeutics, Inc. (CCCC)United States$0.373B-5.65
FENNEC PHARMACEUTICALS INC. (FENC)United States$0.371B-115.85
Surrozen, Inc./DE (SRZN)United States$0.395B
Zura Bio Ltd (ZURA)$0.398B-6.56
Artiva Biotherapeutics, Inc. (ARTV)United States$0.367B
Cabaletta Bio, Inc. (CABA)United States$0.365B-2.81
Scribe Therapeutics, Inc. (SCTX)United States$0.410B
Ocugen, Inc. (OCGN)United States$0.343B-6.34
Editas Medicine, Inc. (EDIT)United States$0.424B-4.29
Kyverna Therapeutics, Inc. (KYTX)United States$0.434B-3.60